Overview
Li Meng practices in Wuhan, China. Meng is rated as an Experienced expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). Their top areas of expertise are Ovarian Cancer, Splenomegaly, Familial Hypofibrinogenemia, and Congenital Afibrinogenemia.
Their clinical research consists of co-authoring 27 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles and participated in 1 clinical trial in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Myelogenous Leukemia (CML)
- Congenital AfibrinogenemiaMeng isExperienced. Learn about Congenital Afibrinogenemia.
- Familial HypofibrinogenemiaMeng isExperienced. Learn about Familial Hypofibrinogenemia.
- HypophosphatemiaMeng isExperienced. Learn about Hypophosphatemia.
- LeukemiaMeng isExperienced. Learn about Leukemia.
- Multiple MyelomaMeng isExperienced. Learn about Multiple Myeloma.